These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9687219)

  • 1. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease.
    Marion JF
    Inflamm Bowel Dis; 1998 May; 4(2):116-7. PubMed ID: 9687219
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine in inflammatory bowel disease, a safe alternative?
    Tanis AA
    Mediators Inflamm; 1998; 7(3):141-4. PubMed ID: 9705598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
    Gisbert JP; Gomollón F; Maté J; Pajares JM
    Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
    [No Abstract]   [Full Text] [Related]  

  • 4. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.
    Nielsen OH; Vainer B; Rask-Madsen J
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1699-708. PubMed ID: 11683683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6TG: when less is more than you bargained for.
    Mahadevan U
    Inflamm Bowel Dis; 2003 Nov; 9(6):394-5. PubMed ID: 14677541
    [No Abstract]   [Full Text] [Related]  

  • 6. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?
    Su CG; Stein RB; Lewis JD; Lichtenstein GR
    Dig Liver Dis; 2000; 32(6):518-31. PubMed ID: 11057928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and treatment of inflammatory bowel disease during pregnancy.
    Brar H; Einarson A
    Can Fam Physician; 2008 Jul; 54(7):981-3. PubMed ID: 18625819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in factor V activity: a new adverse effect of purine analogs in inflammatory bowel diseases?
    Poupeney S; Dray X; Reignier S; Vahedi K; Alhenc M; Belluci S; Marteau P
    Inflamm Bowel Dis; 2008 Jul; 14(7):1024-5. PubMed ID: 18286642
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
    Su C; Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary.
    Griffiths AM
    Inflamm Bowel Dis; 2003 Nov; 9(6):389-91; discussion 392-3. PubMed ID: 14671489
    [No Abstract]   [Full Text] [Related]  

  • 11. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study.
    Nørgård B; Pedersen L; Fonager K; Rasmussen SN; Sørensen HT
    Aliment Pharmacol Ther; 2003 Mar; 17(6):827-34. PubMed ID: 12641505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.
    Kirschner BS
    Gastroenterology; 1998 Oct; 115(4):813-21. PubMed ID: 9753482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Are thiopurines and anti-TNFα agents safe to use in pregnant patients with inflammatory bowel disease?
    Sheibani S; Mahadevan U
    Am J Gastroenterol; 2013 Mar; 108(3):441-3. PubMed ID: 23459048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M; Herrlinger K; Schaeffeler E; Stange EF
    Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergic reactions to 6-mercaptopurine during treatment of inflammatory bowel disease.
    Korelitz BI; Zlatanic J; Goel F; Fuller S
    J Clin Gastroenterol; 1999 Jun; 28(4):341-4. PubMed ID: 10372932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.
    Marshall JK; Otley AR; Afif W; Bernstein CN; Hookey L; Leontiadis G; Panaccione R; Bressler B;
    Can J Gastroenterol Hepatol; 2014; 28(7):371-2. PubMed ID: 25157527
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease.
    de Fonclare AL; Khosrotehrani K; Aractingi S; Duriez P; Cosnes J; Beaugerie L
    Arch Dermatol; 2007 Jun; 143(6):744-8. PubMed ID: 17576940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of thiopurines in the treatment of inflammatory bowel disease.
    de Jong DJ; Derijks LJ; Naber AH; Hooymans PM; Mulder CJ
    Scand J Gastroenterol Suppl; 2003; (239):69-72. PubMed ID: 14743886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two cases of thiopurine-induced acute pancreatitis in inflammatory bowel disease].
    Nishikawa J; Kudo T; Miyazaki T; Mihara H; Ueda A; Ando T; Kajiura S; Fujinami H; Ogawa K; Hosokawa A; Sugiyama T
    Nihon Shokakibyo Gakkai Zasshi; 2012 Feb; 109(2):224-30. PubMed ID: 22306545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.